Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 13/20 | 0.59 |
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29602962 | 1.00 | FFAR1 (0.59) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6956120 | 0.94 | FFAR1 (0.63) | FFAR1PPARAPPARG | |
| SCHEMBL6958784 | 0.93 | FFAR1 (0.58) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6963885 | 0.91 | FFAR1 (0.53) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6964661 | 0.90 | FFAR1 (0.51) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6964001 | 0.90 | PPARG (0.56) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6959497 | 0.90 | MAOB (0.55) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6964875 | 0.90 | FFAR1 (0.61) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6955783 | 0.88 | FFAR1 (0.48) | FFAR1PPARAPPARGCYP3A4 | |
| SCHEMBL6966643 | 0.87 | FFAR1 (0.52) | FFAR1PPARAPPARGCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338480-B2 | Combination treatment of metabolic disorders | WELLSTAT THERAPEUTICS CORPORATION (US) | 2012-12-25 | — | — | US | claimed |
| US-20100292277-A1 | COMBINATION TREATMENT OF METABOLIC DISORDERS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2010-11-18 | — | — | US | claimed |
| EP-2001461-A2 | COMBINATION TREATMENT OF METABOLIC DISORDERS | Wellstat Therapeutics Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| WO-2007117791-A2 | COMBINATION TREATMENT OF METABOLIC DISORDERS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2007-10-18 | — | — | WO | claimed |
| EP-0787725-B1 | QUINOLINE DERIVATIVE | NIPPON CHEMIPHAR CO (JP) | 2003-04-23 | — | — | EP | claimed |
| US-6121288-A | DECREASING VISCERAL FAT, INHIBITING ACCUMULATION OF VISCERAL FAT AND IMPROVING THE DISTRIBUTION OF VISCERAL FAT BY ADMINISTERING A 5-SUBSTITUTED-2,4-THIAZOLIDINEDIONE DERIVATIVE OF GIVEN FORMULA | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-09-19 | — | — | US | claimed |
| EP-0974348-A1 | VISCERAL FAT LOWERING AGENT | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-01-26 | — | — | EP | claimed |
| JP-10182461-A | — | — | None | — | — | JP | disclosed |
| US-20230210808-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | CYMABAY THERAPEUTICS, INC. | 2023-07-06 | — | — | US | disclosed |
| US-11007162-B2 | Methods of reducing small, dense LDL particles | CYMABAY THERAPEUTICS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| US-20190298672-A1 | METHODS OF REDUCING SMALL, DENSE LDL PARTICLES | CYMABAY THERAPEUTICS, INC. (US) | 2019-10-03 | — | — | US | disclosed |
| US-20190192475-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | CYMABAY THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| EP-2346498-B1 | METHODS OF REDUCING SMALL, DENSE LDL PARTICLES | CYMABAY THERAPEUTICS INC (US) | 2018-12-26 | — | — | EP | disclosed |
| WO-2002080935-A1 | COMBINATION THERAPY COMPRISING GLUCOSE REABSORPTION INHIBITORS AND RETINOID-X RECEPTOR MODULATORS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2002-10-17 | — | — | WO | disclosed |
| WO-2000073273-A1 | PROCESS FOR THE PREPARATION OF 2-HALO-3-(3-QUINOLYL)PROPIONIC ACID DERIVATIVES | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-12-07 | — | — | WO | disclosed |
| US-6121288-A | DECREASING VISCERAL FAT, INHIBITING ACCUMULATION OF VISCERAL FAT AND IMPROVING THE DISTRIBUTION OF VISCERAL FAT BY ADMINISTERING A 5-SUBSTITUTED-2,4-THIAZOLIDINEDIONE DERIVATIVE OF GIVEN FORMULA | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| EP-0974348-A1 | VISCERAL FAT LOWERING AGENT | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-01-26 | — | — | EP | disclosed |
| JP-H10182461-A | VISCERAL FAT REDUCING AGENT | NIPPON CHEMIPHAR CO LTD | 1998-07-07 | — | — | JP | disclosed |
| US-5693651-A | HYPOGLYCEMIC AGENTS | NIPPON CHEMIPHAR CO., LTD. (JP) | 1997-12-02 | — | — | US | disclosed |
| EP-0787725-A1 | QUINOLINE DERIVATIVE | NIPPON CHEMIPHAR CO., LTD. (JP) | 1997-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190298672-A1 | METHODS OF REDUCING SMALL, DENSE LDL PARTICLES | LDLR, APOB, HDLBP | FFAR1 1151/4885PPARA 123/4885PPARG 409/4885 |
| US-20190192475-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | PPARA, PPARG, PPARD | FFAR1 34/4885PPARA 1/4885PPARG 2/4885 |
| US-20230210808-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | PPARA, PPARG, PPARD | FFAR1 34/4885PPARA 1/4885PPARG 2/4885 |
| US-20100292277-A1 | COMBINATION TREATMENT OF METABOLIC DISORDERS | NR1H3, GPR119, NR1H2 | FFAR1 6/4885PPARA 13/4885PPARG 12/4885 |
| US-11007162-B2 | Methods of reducing small, dense LDL particles | LDLR, APOB, HDLBP | FFAR1 1151/4885PPARA 123/4885PPARG 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.